chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Slept a lot; bone pain; No appetite; wrists and hands/fingers; Felt ill; muscle pain; slight fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (Slept a lot), BONE PAIN (bone pain), DECREASED APPETITE (No appetite) and PAIN (wrists and hands/fingers) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Flu Vaccine. Concurrent medical conditions included Hypertension, Hyperthyroidism (Post ablative hyperthyroidism), Osteoarthritis (experienced much more pain than usual) since 2019, Osteoporosis (experienced much more pain than usual) since 2019 and Reactive airways disease. Concomitant products included METOPROLOL, PRAVASTATIN, LEVOTHYROXINE and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE & HCTZ) for an unknown indication.   On 26-Feb-2021 at 2:20 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021 at 3:25 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021 at 11:20 AM, the patient experienced PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (Slept a lot), BONE PAIN (bone pain), DECREASED APPETITE (No appetite), PAIN (wrists and hands/fingers), MALAISE (Felt ill), MYALGIA (muscle pain), PYREXIA (slight fever) and CHILLS (Chills). The patient was treated with NAPROXEN at an unspecified dose and frequency. On 29-Mar-2021, PAIN IN EXTREMITY (Sore arm), HYPERSOMNIA (Slept a lot), BONE PAIN (bone pain), DECREASED APPETITE (No appetite), PAIN (wrists and hands/fingers), MALAISE (Felt ill), MYALGIA (muscle pain), PYREXIA (slight fever) and CHILLS (Chills) had resolved.
Sex: U
Vaccine: COVID19
Symptoms: Blood pressure measurement, Gastrooesophageal reflux disease, Hypertension, Myalgia
Clinical narrative: hypertension; Acid reflux; Muscle pain in my legs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (hypertension), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) and MYALGIA (Muscle pain in my legs) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal) and Blood pressure high (Blood pressure).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (hypertension), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) and MYALGIA (Muscle pain in my legs). At the time of the report, HYPERTENSION (hypertension), GASTROOESOPHAGEAL REFLUX DISEASE (Acid reflux) and MYALGIA (Muscle pain in my legs) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: higher (High) Higher.         No concomitant medications were provided. Treatment medications were unknown.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed the second dose because of surgery; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the second dose because of surgery) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 2033B21A and 044A01) for COVID-19 vaccination.     The patient's past medical history included Surgery (2nd Dose Delayed due to Surgery).   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the second dose because of surgery). On 28-May-2021, PRODUCT DOSE OMISSION ISSUE (Missed the second dose because of surgery) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment was reported.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Prothrombin level decreased, Prothrombin time, Pyrexia
Clinical narrative: decreased prothrombin level; decreased prothrombin level; PAIN IN ARM; Fever; This spontaneous case was reported by a consumer and describes the occurrence of the first episode of PROTHROMBIN LEVEL DECREASED (decreased prothrombin level), the second episode of PROTHROMBIN LEVEL DECREASED (decreased prothrombin level), PAIN IN EXTREMITY (PAIN IN ARM) and PYREXIA (Fever) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 003C21A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation, Coronary artery disease, Glaucoma since 2006, Enlarged prostate since 2015 and Restless leg syndrome since 2006. Concomitant products included WARFARIN and METOPROLOL for AFib, CYANOCOBALAMIN (B-12) for Bacterial infection NOS, FUROSEMIDE (LASIX P) and PRAVASTATIN for Coronary heart disease, TAMSULOSIN for Enlarged prostate, DORZOLAMIDE HCL for Glaucoma, DIGOXIN for Heart disorder, PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE [PRAMIPEXOLE DIHYDROCHLORIDE]) for Restless leg syndrome, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced PAIN IN EXTREMITY (PAIN IN ARM) and PYREXIA (Fever). On 28-May-2021, the patient experienced the first episode of PROTHROMBIN LEVEL DECREASED (decreased prothrombin level). On 11-Jun-2021, the patient experienced the second episode of PROTHROMBIN LEVEL DECREASED (decreased prothrombin level). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, last episode of PROTHROMBIN LEVEL DECREASED (decreased prothrombin level) had not resolved and PAIN IN EXTREMITY (PAIN IN ARM) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-May-2021, Prothrombin time (2.0-3.0): 1.4 (Low) Low.         Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Added height,weight,race,AE contact info and new events.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: pain became worst till now; severe pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (severe pain) and PAIN (pain became worst till now) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039D21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN (severe pain). On an unknown date, the patient experienced PAIN (pain became worst till now). At the time of the report, PAIN (severe pain) and PAIN (pain became worst till now) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information was reported.       Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling, Pruritus, Tenderness
Clinical narrative: Mild reaction, Covid arm; Red arm; Itchy arm; Hot; Swollen; Tender; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (Mild reaction, Covid arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), FEELING HOT (Hot) and PERIPHERAL SWELLING (Swollen) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Mild reaction, Covid arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), FEELING HOT (Hot), PERIPHERAL SWELLING (Swollen) and TENDERNESS (Tender). At the time of the report, VACCINATION SITE REACTION (Mild reaction, Covid arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), FEELING HOT (Hot), PERIPHERAL SWELLING (Swollen) and TENDERNESS (Tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications include blood pressure medication and cholesterol medication
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Mild reaction, Covid arm; Red arm; Itchy arm; Hot; Swollen; Tender; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (Mild reaction, Covid arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), FEELING HOT (Hot) and PERIPHERAL SWELLING (Swollen) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Mild reaction, Covid arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), FEELING HOT (Hot), PERIPHERAL SWELLING (Swollen) and TENDERNESS (Tender). At the time of the report, VACCINATION SITE REACTION (Mild reaction, Covid arm), ERYTHEMA (Red arm), PRURITUS (Itchy arm), FEELING HOT (Hot), PERIPHERAL SWELLING (Swollen) and TENDERNESS (Tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications include blood pressure medication and cholesterol medication
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Heavy Vaginal Bleeding; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Heavy Vaginal Bleeding) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced VAGINAL HAEMORRHAGE (Heavy Vaginal Bleeding). On 17-May-2021, VAGINAL HAEMORRHAGE (Heavy Vaginal Bleeding) had resolved.            Concomitant medications were not provided Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed 2nd  dose of vaccine, Day90 after the 1st dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-May-2021 and was forwarded to Moderna on 28-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed 2nd  dose of vaccine, Day90 after the 1st dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed 2nd  dose of vaccine, Day90 after the 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed 2nd  dose of vaccine, Day90 after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported , No treatment medication was reported .   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: FU received but concern not provided data On 10-Jun-2021: Initial Additional-2 : To confirm a true duplicate of Initial Additional 1
Sex: U
Vaccine: COVID19
Symptoms: Extra dose administered, Vaccination site mass
Clinical narrative: lump at injection site; got 3 shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (lump at injection site) and EXTRA DOSE ADMINISTERED (got 3 shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (lump at injection site) and EXTRA DOSE ADMINISTERED (got 3 shot). At the time of the report, VACCINATION SITE MASS (lump at injection site) outcome was unknown and EXTRA DOSE ADMINISTERED (got 3 shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Peripheral swelling, Pyrexia, Rash
Clinical narrative: swelling in her arm; rash; her temperature is 101F; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in her arm), RASH (rash) and PYREXIA (her temperature is 101F) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 06c21a) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020.    On 27-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swelling in her arm), RASH (rash) and PYREXIA (her temperature is 101F). At the time of the report, PERIPHERAL SWELLING (swelling in her arm), RASH (rash) and PYREXIA (her temperature is 101F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (Inconclusive) temperature is 101F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Ocular discomfort
Clinical narrative: Eyes have been bothering me/eyes have waste; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (Eyes have been bothering me/eyes have waste) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OCULAR DISCOMFORT (Eyes have been bothering me/eyes have waste). At the time of the report, OCULAR DISCOMFORT (Eyes have been bothering me/eyes have waste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pyrexia
Clinical narrative: fever; muscular pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), MYALGIA (muscular pain) and FATIGUE (fatigue) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced PYREXIA (fever), MYALGIA (muscular pain) and FATIGUE (fatigue). At the time of the report, PYREXIA (fever), MYALGIA (muscular pain) and FATIGUE (fatigue) outcome was unknown.            Concomitant product use included blood pressure medications.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed window for second dose; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed window for second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed window for second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed window for second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Vaccination site swelling
Clinical narrative: Swelling at the injection site; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site) and PAIN (Soreness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site) and PAIN (Soreness). At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site) and PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: under 18 years old, received the vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old, received the vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old, received the vaccine). On 28-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (under 18 years old, received the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Hypertension, Tachycardia
Clinical narrative: Blood pressure rise; heart rate went up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Blood pressure rise) and TACHYCARDIA (heart rate went up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERTENSION (Blood pressure rise) and TACHYCARDIA (heart rate went up). At the time of the report, HYPERTENSION (Blood pressure rise) and TACHYCARDIA (heart rate went up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high (High) High. On an unknown date, Heart rate: high (High) High.         No concomitant medications were provided.   No treatment medications were provided.  Action taken in response to mRNA-1273 was considered to be not applicable.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Nerve injury, Pain, Rotator cuff syndrome, Vaccination site pain
Clinical narrative: left arm has been killing him; range of motion is limited; rotator cuff injury; nerve damage; arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (left arm has been killing him), MOBILITY DECREASED (range of motion is limited), ROTATOR CUFF SYNDROME (rotator cuff injury), NERVE INJURY (nerve damage) and VACCINATION SITE PAIN (arm is sore) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (left arm has been killing him), MOBILITY DECREASED (range of motion is limited), ROTATOR CUFF SYNDROME (rotator cuff injury), NERVE INJURY (nerve damage) and VACCINATION SITE PAIN (arm is sore). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at a dose of 1 dosage form. At the time of the report, PAIN (left arm has been killing him), MOBILITY DECREASED (range of motion is limited), ROTATOR CUFF SYNDROME (rotator cuff injury), NERVE INJURY (nerve damage) and VACCINATION SITE PAIN (arm is sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable  No concomitant medications were reported
Sex: U
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Face started tingling; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Face started tingling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Face started tingling). At the time of the report, PARAESTHESIA (Face started tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Allergy to vaccine, Pruritus
Clinical narrative: allergic reaction; whole body itching still suffering with itches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (allergic reaction) and PRURITUS (whole body itching still suffering with itches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALLERGY TO VACCINE (allergic reaction) and PRURITUS (whole body itching still suffering with itches). At the time of the report, ALLERGY TO VACCINE (allergic reaction) and PRURITUS (whole body itching still suffering with itches) had not resolved.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Unexplained rapid heart palpitations; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Unexplained rapid heart palpitations) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (Unexplained rapid heart palpitations). At the time of the report, PALPITATIONS (Unexplained rapid heart palpitations) outcome was unknown.            Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 30.0
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developing shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Developing shingles) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Developing shingles). At the time of the report, HERPES ZOSTER (Developing shingles) outcome was unknown.            It was reported that patient had developed shingles and got treated 72 hours after second Moderna vaccine     No concomitant medication was reported  No treatment medication was reported
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disorientation, Dizziness, Erythema, Feeling hot
Clinical narrative: she is Cranky and it is driving her crazy; arm was red; Itchy; Hard to touch; Headache; Chills; Very sick; Disoriented; Hot; Dizziness; This spontaneous case was reported by a patient and describes the occurrence of IRRITABILITY (she is Cranky and it is driving her crazy), DISORIENTATION (Disoriented), FEELING HOT (Hot), DIZZINESS (Dizziness) and ERYTHEMA (arm was red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.  Concomitant products included ESTRADIOL, ACETYLSALICYLIC ACID (ASPIRIN 81), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), BIOTIN, VITAMIN B12 [VITAMIN B12 NOS] and MAGNESIUM CITRATE NONAHYDRATE for an unknown indication.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On 27-Apr-2021, the patient experienced DISORIENTATION (Disoriented), FEELING HOT (Hot), DIZZINESS (Dizziness), MALAISE (Very sick) and CHILLS (Chills). On 28-Apr-2021, the patient experienced IRRITABILITY (she is Cranky and it is driving her crazy), ERYTHEMA (arm was red), PRURITUS (Itchy), INDURATION (Hard to touch) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 mg. At the time of the report, IRRITABILITY (she is Cranky and it is driving her crazy), DISORIENTATION (Disoriented), FEELING HOT (Hot), DIZZINESS (Dizziness), ERYTHEMA (arm was red), PRURITUS (Itchy), INDURATION (Hard to touch), MALAISE (Very sick), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient had stated that Benadryl gel did not help and Benadryl 25mg put her to sleep
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Induration, Irritability, Malaise, Pruritus
Clinical narrative: she is Cranky and it is driving her crazy; arm was red; Itchy; Hard to touch; Headache; Chills; Very sick; Disoriented; Hot; Dizziness; This spontaneous case was reported by a patient and describes the occurrence of IRRITABILITY (she is Cranky and it is driving her crazy), DISORIENTATION (Disoriented), FEELING HOT (Hot), DIZZINESS (Dizziness) and ERYTHEMA (arm was red) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022B21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history provided by the reporter.  Concomitant products included ESTRADIOL, ACETYLSALICYLIC ACID (ASPIRIN 81), COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), BIOTIN, VITAMIN B12 [VITAMIN B12 NOS] and MAGNESIUM CITRATE NONAHYDRATE for an unknown indication.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form(s). On 27-Apr-2021, the patient experienced DISORIENTATION (Disoriented), FEELING HOT (Hot), DIZZINESS (Dizziness), MALAISE (Very sick) and CHILLS (Chills). On 28-Apr-2021, the patient experienced IRRITABILITY (she is Cranky and it is driving her crazy), ERYTHEMA (arm was red), PRURITUS (Itchy), INDURATION (Hard to touch) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 mg. At the time of the report, IRRITABILITY (she is Cranky and it is driving her crazy), DISORIENTATION (Disoriented), FEELING HOT (Hot), DIZZINESS (Dizziness), ERYTHEMA (arm was red), PRURITUS (Itchy), INDURATION (Hard to touch), MALAISE (Very sick), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient had stated that Benadryl gel did not help and Benadryl 25mg put her to sleep
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Hypoaesthesia, Influenza
Clinical narrative: tingling in hand and forearm; numbness in hand and forearm; pain in her right shoulder blade down through injection site, down arm muscle/down arm muscle; flu symptoms; chills; fever; weakness; could not lift her head; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA (flu symptoms), PARAESTHESIA (tingling in hand and forearm), ASTHENIA (weakness), MOVEMENT DISORDER (could not lift her head) and HYPOAESTHESIA (numbness in hand and forearm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Back pain and Pinched nerve.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 23-Apr-2021, the patient experienced INFLUENZA (flu symptoms), ASTHENIA (weakness), MOVEMENT DISORDER (could not lift her head), CHILLS (chills) and PYREXIA (fever). In May 2021, the patient experienced PARAESTHESIA (tingling in hand and forearm), HYPOAESTHESIA (numbness in hand and forearm) and MYALGIA (pain in her right shoulder blade down through injection site, down arm muscle/down arm muscle). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. On 24-Apr-2021, INFLUENZA (flu symptoms) had resolved. At the time of the report, PARAESTHESIA (tingling in hand and forearm), ASTHENIA (weakness), MOVEMENT DISORDER (could not lift her head), CHILLS (chills), PYREXIA (fever) and MYALGIA (pain in her right shoulder blade down through injection site, down arm muscle/down arm muscle) outcome was unknown and HYPOAESTHESIA (numbness in hand and forearm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.         No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Movement disorder, Myalgia, Paraesthesia, Pyrexia
Clinical narrative: tingling in hand and forearm; numbness in hand and forearm; pain in her right shoulder blade down through injection site, down arm muscle/down arm muscle; flu symptoms; chills; fever; weakness; could not lift her head; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA (flu symptoms), PARAESTHESIA (tingling in hand and forearm), ASTHENIA (weakness), MOVEMENT DISORDER (could not lift her head) and HYPOAESTHESIA (numbness in hand and forearm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Back pain and Pinched nerve.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 23-Apr-2021, the patient experienced INFLUENZA (flu symptoms), ASTHENIA (weakness), MOVEMENT DISORDER (could not lift her head), CHILLS (chills) and PYREXIA (fever). In May 2021, the patient experienced PARAESTHESIA (tingling in hand and forearm), HYPOAESTHESIA (numbness in hand and forearm) and MYALGIA (pain in her right shoulder blade down through injection site, down arm muscle/down arm muscle). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. On 24-Apr-2021, INFLUENZA (flu symptoms) had resolved. At the time of the report, PARAESTHESIA (tingling in hand and forearm), ASTHENIA (weakness), MOVEMENT DISORDER (could not lift her head), CHILLS (chills), PYREXIA (fever) and MYALGIA (pain in her right shoulder blade down through injection site, down arm muscle/down arm muscle) outcome was unknown and HYPOAESTHESIA (numbness in hand and forearm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Body temperature: inconclusive (Inconclusive) Inconclusive.         No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Sex: U
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Back pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced BACK PAIN (Back pain). At the time of the report, BACK PAIN (Back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided by the reporter no treatment information reported by the reporter   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Bradycardia, Heart rate
Clinical narrative: heart rate low; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BRADYCARDIA (heart rate low) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced BRADYCARDIA (heart rate low). At the time of the report, BRADYCARDIA (heart rate low) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2021, Heart rate: low (Low) low heart rate.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided. Based on current available information and the temporal association between product use and the start date of the event a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the event a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Pruritus
Clinical narrative: Itching; Injection spot red; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and INJECTION SITE ERYTHEMA (Injection spot red) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching) and INJECTION SITE ERYTHEMA (Injection spot red). At the time of the report, PRURITUS (Itching) and INJECTION SITE ERYTHEMA (Injection spot red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided  No treatment medications provided
Sex: U
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching; Small rash after first shot; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and RASH (Small rash after first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching) and RASH (Small rash after first shot). At the time of the report, PRURITUS (Itching) and RASH (Small rash after first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter.  No treatment medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Yes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Yes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Yes). At the time of the report, VACCINATION COMPLICATION (It sounds like you have received the Moderna COVID-19 Vaccine and have experienced a side effect. Yes) outcome was unknown.            Concomitant medication were not reported Treatment medication were not reported
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Chills, Myalgia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Didn't have taste; Fever; Body aches; Chills; This spontaneous prospective pregnancy case was reported by a patient and describes the occurrence of AGEUSIA (Didn't have taste), PYREXIA (Fever), MYALGIA (Body aches) and CHILLS (Chills) in a 21-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concomitant products included PROMETHAZINE for Nausea and Vomiting.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 26-Mar-2021 and the estimated date of delivery was 31-Dec-2021. On an unknown date, the patient experienced AGEUSIA (Didn't have taste), PYREXIA (Fever), MYALGIA (Body aches) and CHILLS (Chills). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, AGEUSIA (Didn't have taste), PYREXIA (Fever), MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-May-2021, SARS-CoV-2 test: positive (Positive) COVID-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reports that she is currently in a high-risk pregnancy.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Confusional state, Feeling abnormal, Headache, Nausea
Clinical narrative: Mental confusion; foggy brain; Nausea; Headache; This spontaneous case was reported by a patient family member or friend and describes the occurrence of CONFUSIONAL STATE (Mental confusion), FEELING ABNORMAL (foggy brain), NAUSEA (Nausea) and HEADACHE (Headache) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-May-2021, the patient experienced CONFUSIONAL STATE (Mental confusion), FEELING ABNORMAL (foggy brain), NAUSEA (Nausea) and HEADACHE (Headache). At the time of the report, CONFUSIONAL STATE (Mental confusion), FEELING ABNORMAL (foggy brain), NAUSEA (Nausea) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Vaccination site pain
Clinical narrative: more than half of vaccine leaked; slight injection site pain; This spontaneous case was reported by a patient and describes the occurrence of ACCIDENTAL UNDERDOSE (more than half of vaccine leaked) and VACCINATION SITE PAIN (slight injection site pain) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037c21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, the patient experienced ACCIDENTAL UNDERDOSE (more than half of vaccine leaked) and VACCINATION SITE PAIN (slight injection site pain). On 28-May-2021, ACCIDENTAL UNDERDOSE (more than half of vaccine leaked) had resolved. At the time of the report, VACCINATION SITE PAIN (slight injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided  No treatment medications provided
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effect (Does the vaccine affect the nervous system in any way?); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect (Does the vaccine affect the nervous system in any way?)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect (Does the vaccine affect the nervous system in any way?)). At the time of the report, VACCINATION COMPLICATION (side effect (Does the vaccine affect the nervous system in any way?)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not provided.